BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, December 20, 2024
See today's BioWorld MedTech
Home
» Nevro wins CE mark for spinal cord stimulation technology
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Nevro wins CE mark for spinal cord stimulation technology
Nov. 13, 2024
By
Shani Alexander
No Comments
Nevro Corp. received CE mark certification for its HFX iQ spinal cord stimulation system that delivers pain relief.
BioWorld MedTech
Regulatory
Digital health
U.S.
